CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+9.06%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.6B
AUM Growth
+$2.59B
(+22%)
Cap. Flow
+$828M
Cap. Flow
% of AUM
5.67%
Top 10 Holdings %
Top 10 Hldgs %
21.92%
Holding
968
New
130
Increased
364
Reduced
334
Closed
74
Top Buys
| 1 |
Microsoft
MSFT
|
$144M |
| 2 |
Royal Bank of Canada
RY
|
$123M |
| 3 |
Agilent Technologies
A
|
$78.5M |
| 4 |
UnitedHealth
UNH
|
$71.8M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$70.8M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$92.6M |
| 2 |
Amgen
AMGN
|
$87.9M |
| 3 |
Allstate
ALL
|
$52.7M |
| 4 |
PayPal
PYPL
|
$47.9M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
$47.4M |
Sector Composition
| 1 | Healthcare | 33.43% |
| 2 | Technology | 23.21% |
| 3 | Consumer Discretionary | 9.15% |
| 4 | Financials | 8.64% |
| 5 | Communication Services | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Karyopharm Therapeutics
KPTI
$57.2M
| $7.41M | 0.05% |
47,845
-15,593
| -25% | -$2.41M |
|
327
Thomson Reuters
TRI
$78.7B
| $7.38M | 0.05% |
71,530
-19,532
| -21% | -$2.01M |
|
|
RDUS
328
DELISTED
Radius Health, Inc.
RDUS
| $7.35M | 0.05% |
403,068
+50,501
| +14% | +$921K |
|
|
FMTX
329
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $7.29M | 0.05% |
292,692
+169,688
| +138% | +$4.22M |
|
330
Blink Charging
BLNK
$117M
| $7.26M | 0.05% |
176,342
+176,320
| +801,455% | +$7.26M |
|
|
ALLK
331
DELISTED
Allakos
ALLK
| $7.21M | 0.05% |
66,054
-2,897
| -4% | -$316K |
|
332
Tandem Diabetes Care
TNDM
$850M
| $7.17M | 0.05% |
73,587
+21,217
| +41% | +$2.07M |
|
|
UMPQ
333
DELISTED
Umpqua Holdings Corp
UMPQ
| $7.15M | 0.05% |
+387,416
| New | +$7.15M |
|
334
American Eagle Outfitters
AEO
$3.26B
| $7.1M | 0.05% |
+189,260
| New | +$7.1M |
|
335
Infosys
INFY
$67.9B
| $7.07M | 0.05% |
333,594
+12,356
| +4% | +$262K |
|
336
W.W. Grainger
GWW
$47.5B
| $7.03M | 0.05% |
13,966
+4,165
| +42% | +$2.1M |
|
337
89bio
ETNB
$1.32B
| $6.98M | 0.05% |
+373,473
| New | +$6.98M |
|
338
Zebra Technologies
ZBRA
$16B
| $6.91M | 0.05% |
13,053
+1,070
| +9% | +$567K |
|
339
Theravance Biopharma
TBPH
$703M
| $6.91M | 0.05% |
+475,696
| New | +$6.91M |
|
|
GBT
340
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $6.88M | 0.05% |
+196,330
| New | +$6.88M |
|
341
New Oriental
EDU
$7.98B
| $6.87M | 0.05% |
83,866
+61,383
| +273% | +$5.03M |
|
342
Atmos Energy
ATO
$26.7B
| $6.85M | 0.05% |
71,241
-30,798
| -30% | -$2.96M |
|
343
Sutro Biopharma
STRO
$89.9M
| $6.81M | 0.05% |
366,207
-1,903
| -0.5% | -$35.4K |
|
344
Dyne Therapeutics
DYN
$2.02B
| $6.8M | 0.05% |
+323,393
| New | +$6.8M |
|
|
HARP
345
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $6.79M | 0.05% |
48,951
+48,948
| +1,631,600% | +$6.79M |
|
346
CNO Financial Group
CNO
$3.85B
| $6.78M | 0.05% |
+287,217
| New | +$6.78M |
|
347
Acadia Pharmaceuticals
ACAD
$4.26B
| $6.72M | 0.05% |
275,560
-23,328
| -8% | -$569K |
|
348
Fidelity National Information Services
FIS
$35.9B
| $6.66M | 0.05% |
47,008
-8,662
| -16% | -$1.23M |
|
349
FedEx
FDX
$53.7B
| $6.63M | 0.05% |
22,207
+4,061
| +22% | +$1.21M |
|
350
Avery Dennison
AVY
$13.1B
| $6.59M | 0.05% |
31,341
+6,544
| +26% | +$1.38M |
|